Solicitude from leadership

HOME
About Us

Company Profile President Oration Solicitude From Leadership Development Process Contact Us

About Us

Established in 1998, went public in May 2012, Dongcheng Biochemicals Co.,Ltd has developed into an enterprise group which combines ……
NEWS

Announcement Company News

NEWS

Dongcheng Pharmaceutical has continuously increased its investment in scientific research and is committed to independent innovation.
Products

Heparin Series Chondroitin Sulphate Series Marine Collagen Hyaluronic Acid Glucosamine Series Heparinoid Cytochrome C

Products

Dongcheng Pharmaceutical has continuously increased its investment in scientific research and is committed to independent innovation.
Branch

Yantai Dongcheng Beifang Pharmaceutical Co.,Ltd Yantai Dongcheng Dayang Pharmaceutical Co.,Ltd Linyi Dongcheng Dongyuan Biological Engineering Co.,Ltd Dongcheng Bionchemicals(USA) Inc

Branch

China's radiopharmaceutical industry is still in its infancy. In 2013, the output value of radio medicines nationwide was 2 billion yuan,
Service and Support

Quality Assurance Product Certification Research Ad Development Guara

Service and Support

DCB now is one of the biggest biochemical API manufacturers in China, With leading production technology, reliable product quality and excellent international qualification background,
Human Resources
Investor Relations

Real-time stock price Financial report Shareholders meeting Real-time stock price

Investor Relations

Care for life with sincerity, Continuous innovation, striving for perfection! In the future, DCB will carry on the mission of serving human health,

Solicitude from leadership

YOUR LOCATION：HOME >> ABOUT US

In Sep. 2013, Sang Guowei, vice chairman of the standing committee of the 11th National People’s Congress, visited Dongcheng Biochemicals. He spoke highly of the efforts achieved through implementing particular task，biological pharmaceutical research and development. He pointed out that biological pharmaceutical industry is an emerging industry that we have to accelerate the R&D and industrialization process of it, and struggle to achieve breakthrough by providing powerful support to creative products.

On March 5, 2013, the vice Mayor Yan Weihua investigated the biological pharmaceutical industry of Dongcheng Biochemicals Co., Ltd.